Corneal Neovascularisation and Scleral Contact Lenses: Why Oxygen Matters

Corneal Neovascularisation and Scleral Contact Lenses: Why Oxygen Matters

Right eye of a patient showing significant corneal neovascularisation. Left eye of the same patient, without comparable corneal neovascularisation. Corneal neovascularisation refers to the growth of new blood vessels into the cornea. The cornea is normally clear and largely avascular, which is one of the reasons it can transmit light so effectively. When blood vessels… Continue reading Corneal Neovascularisation and Scleral Contact Lenses: Why Oxygen Matters

Scleral Contact Lens Fog

What happens over the day Immediately after insertion, the reservoir is mostly preservative-free filling solution mixed with some basal tears. During wear, several things occur: Does pH change? Probably yes, but direct human data measuring reservoir pH over time is limited. Mechanistically, the post-lens reservoir can drift more acidic because: So the concern is not… Continue reading Scleral Contact Lens Fog

Dr Rebecca Kitson at the J&J Contact Lens Leaders Summit in Sydney May 24-25 2026:

Enables us to be one of the First Practices in Australia to Offer the New J&J Daily Disposable Multifocal Toric Contact Lens At Mark Hinds Optometrists, we are proud to continue leading the way in advanced contact lens technology — becoming one of the first practices in Australia to fit the new Johnson & Johnson… Continue reading Dr Rebecca Kitson at the J&J Contact Lens Leaders Summit in Sydney May 24-25 2026:

Advancing Care for Patients with Ocular Graft-versus-Host Disease (oGVHD)

Our care and research: At Mark Hinds Optometrists and Ophthalmic Trials Australia (OTA), our team is committed to improving the lives of patients living with severe ocular surface disease through research, innovation, and compassionate clinical care. One area of increasing focus is ocular graft-versus-host disease (oGVHD) — a potentially debilitating complication that can occur following… Continue reading Advancing Care for Patients with Ocular Graft-versus-Host Disease (oGVHD)

ARVO 2026 Denver

The team from Mark Hinds Optometrists and Ophthalmic Trials Australia recently attended and presented at the 2026 Annual Meeting of the Association for Research in Vision and Ophthalmology in Denver, Colorado. ARVO remains one of the world’s leading scientific meetings in ophthalmology and vision science, bringing together clinicians, researchers, industry leaders, and innovators from around… Continue reading ARVO 2026 Denver